Avantor, Inc. (AVTR): Operating Income
-$246.20M
Year ended 2025-12-31
-$294.10M
Trailing 12 months to 2026-03-31
| Period ended | Operating Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$246.20M | n/m | 2026-02-11, From 2025-01-01 |
| 2024-12-31 | $1.08B | +55.8% | 2026-02-11, From 2024-01-01 |
| 2023-12-31 | $696.40M | -38.4% | 2026-02-11, From 2023-01-01 |
| 2022-12-31 | $1.13B | +16.3% | 2025-02-07, From 2022-01-01 |
| 2021-12-31 | $972.20M | +37.5% | 2024-02-14, From 2021-01-01 |
| 2020-12-31 | $706.80M | +28.1% | 2023-02-14, From 2020-01-01 |
| 2019-12-31 | $551.80M | +33.4% | 2022-02-11, From 2019-01-01 |
| 2018-12-31 | $413.50M | n/m | 2021-02-16, From 2018-01-01 |
| 2017-12-31 | -$210.40M | n/a | 2020-02-14, From 2017-01-01 |
Operating Income at similar companies
| Company | Year ended | Operating Income | Change YoY |
|---|---|---|---|
| Avantor, Inc. (AVTR) | 2025-12-31 | -$246.20M | n/m |
| Agilent Technologies, Inc. (A) | 2025-10-31 | $1.48B | -0.6% |
| Illumina, Inc. (ILMN) | 2025-12-28 | $807.00M | n/m |
| Bruker Corp (BRKR) | 2025-12-31 | $68.20M | -73.1% |
| Waters Corp (WAT) | 2025-12-31 | $802.59M | -2.9% |
| Revvity, Inc. (RVTY) | 2025-12-28 | $356.63M | +2.9% |
| Bio-Rad Laboratories, Inc. (BIO) | 2025-12-31 | $47.20M | -82.5% |
| 10x Genomics, Inc. (TXG) | 2025-12-31 | -$60.98M | n/m |
| Cytek Biosciences, Inc. (CTKB) | 2025-12-31 | -$40.38M | n/m |
Compare AVTR, A, ILMN, BRKR side by side · Screen every company in Laboratory Analytical Instruments ↗